• Twitter
  • Facebook
  • LinkedIn
Biweekly newsletter of the International Cytokine & Interferon Society

Biweekly newsletter of the International Cytokine & Interferon Society

Signals+ Editors: Daniella Schwartz & Di Yu (Editors in Chief), Saurabh Chattopadhyay, Zhian Chen, Mohamed Saad & Maialen Sebastian-delaCruz
  • Subscribe to Signals+
  • Signals+ Past Issues (Oct. 2023 – Present)
    • Signals+ October 2022 PDF
    • Signals+ April 2022 PDF
    • Signals+ April 2021 PDF
HomePast MeetingsCytokines 2022 Hybrid Joint Meeting with ILC4

Cytokines 2022 Hybrid Joint Meeting with ILC4

October 31, 2023 Past Meetings

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Previous

Jiyoung Kim, PhD candidate

Next

Cytokines 2023

Beyond Sciences Initiative Announces its 10th Annual Science & Society Conference - February 21, 22, and March 6, 2025
Other Meetings

Beyond Sciences Initiative Announces its 10th Annual Science & Society Conference – February 21, 22, and March 6, 2025

November 4, 2024

Science & Society is a free online conference that provides scholars worldwide an opportunity to present their research and network with a broad scientific audience. Topics include infectious diseases, non-communicable diseases, cancer, bioinformatics and AI. [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Image of Howard Young titled: From Howard's Desk
From Howard's Desk

The World of a Science Retiree Advice

November 4, 2024

By Howard Young, Retired Principal Investigator, National Cancer Institute, Frederick, Maryland, USA Having been retired for 10 months, I thought I would provide a bit of advice of what to expect in retirement for someone who had a scientific career. Drs. Sharon Wahl and Charlie Glinka contributed some thoughts to [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
ICIS President and President-Elect, Sarah Gaffen and Curt Horvath in front of Gang Nam hands, Seoul, Korea
Featured Article!

Cytokines2024 Rocks, Gang Nam Style

November 4, 2024

There’s no doubt, Cytokines2024 in Seoul, Korea was a resounding success. The ICIS/KAI joint meeting boasted nearly 2,000 attendees from 36 countries, 55 invited speakers, 55 pharma and vendor sponsors, > 600 posters, 20 junior and senior research awards, 47 ICIS travel awards, and a Nobel Laureate. The conference was [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Dr. Mariana J Kaplan, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
New Member Mini-Bios

Dr. Mariana J Kaplan, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health

November 4, 2024

Mariana Kaplan, M.D. is NIH Distinguished Investigator, Chief of the Systemic Autoimmunity Branch and Deputy Scientific Director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health. She is a rheumatologist whose research has focused on identifying mechanisms of immune dysregulation, organ damage, and premature vascular disease in systemic autoimmunity. Specifically, she investigates how innate immunity (in particular, type I interferons and myeloid cells) promotes autoimmune responses and end-organ damage in systemic lupus erythematosus, rheumatoid arthritis, and other systemic autoimmune diseases. [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Reviews of Interest

Reviews of Interest Curated by Dr. Zhian (Anthony) Chen

November 3, 2024

Photo Credit: Burcu Elmas (pexels.com 10051526) A guide to adaptive immune memory.PMID: 38831162Lam N, Lee Y, Farber DL.Nat Rev Immunol. 2024 Jun 3. doi: 10.1038/s41577-024-01040-6. Online ahead of print.PMID: 38831162 Review. Towards a unifying model for B-cell receptor triggering.PMID: 39256626Degn SE, Tolar P.Nat Rev Immunol. 2024 Sep 10. doi: 10.1038/s41577-024-01073-x. Online ahead [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Faculty positions available at the University of Pittsburgh Department of Immunology
Cytokine Careers

Faculty positions available at the University of Pittsburgh Department of Immunology

November 3, 2024

The University of Pittsburgh Department of Immunology is delighted to announce three open faculty positions: one at Full/Associate Professor (tenured) and two at Assistant Professor (tenure stream). The Department of Immunology at the University of Pittsburgh School of Medicine is expanding its primary faculty base and invites applicants focused on [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials for the week of November 6

November 3, 2024

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
New CSF Biomarkers for Alzheimer’s Disease (BioAD)
Interleukin and Autoantibodies in Myasthenia Gravis [READ MORE]

Share this:

  • Click to share on X (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy

Go to mobile version
 

Loading Comments...